Synthesis of Ethylene Oxide as a fumigant
Posted on July 29, 2008 in Diabetes erectile dysfunction
That becomes the synthesis of ethlyene oxide which can be used while a fumigant owing to foods, textiles, soils along whereas sterilizing biomedical instruments. It simply diffuses effected data fewer damanging them. Its antibacterial beget is probably capital to its endowment to alkylate critical cellular enzymes. Heres a lock
Inspire Announces Licensing Agreement
Posted on July 15, 2008 in Antibiotic
Inspire (NASDAQ:ISPH) is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs. The research and development programs of Inspire are driven by extensive scientific experience in the therapeutic areas of ophthalmology and respiratory/allergy, and supported by expertise in the field of P2 receptors. Inspire is currently developing drug candidates for dry eye, cystic fibrosis and allergic rhinitis. Inspire's U.S. specialty sales force promotes Elestat (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis (cyclosporine ophthalmic emulsion) 0.05% for dry eye, ophthalmology products developed by Allergan, Inc. Elestat and Restasis are trademarks owned by Allergan. AzaSite(TM) and DuraSite are trademarks owned by InSite Vision Inc. For more information, visit www.inspirepharm.com. At the time of writing shares are up 4% to $7.67 with over 324,000 in volume. This momentum comes as Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the signing of an exclusive licensing agreement with InSite Vision Incorporated (AMEX: ISV) for the U.S. and Canadian commercialization of AzaSite(TM) (1.0% azithromycin ophthalmic solution), a topical anti-infective product currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of bacterial conjunctivitis. MarketGainer.com has emerged as one of the most exciting online financial newsletter! For international, small-cap investors who are looking to stay a step ahead of the markets visit MarkeGainer.com. Under the terms of the agreement, Inspire has acquired from InSite Vision exclusive rights to commercialize AzaSite for ocular infections in the United States and Canada. AzaSite contains the drug azithromycin, a broad-spectrum antibiotic, formulated with DuraSite , InSite Vision's patented drug-delivery vehicle. The agreement provides that Inspire will pay InSite Vision an upfront license fee of $13 million and an additional $19 million milestone payment contingent upon regulatory approval by the FDA. Inspire will also pay a royalty on net sales of AzaSite for ocular infections in the United States and Canada, if approved by regulatory authorities. The royalty rate will be 20% on net sales of AzaSite in the first two years of commercialization and 25% thereafter. Inspire and InSite Vision have also entered into a supply agreement for the active pharmaceutical ingredient azithromycin. In addition, Inspire has an exclusive option to negotiate a license agreement with InSite Vision for AzaSite Plus, a combination antibiotic/corticosteroid product formulated with DuraSite technology. Christy L. Shaffer, Ph.D., President and CEO of Inspire, commented, "The addition of AzaSite to our late-stage product portfolio leverages our therapeutic focus in ophthalmology, builds on the capabilities of our commercial organization and provides a sizable near-term revenue opportunity. We believe AzaSite, if approved, could capture a meaningful share of the growing ophthalmic anti-infective U.S. prescription market, which exceeds $600 million for both single-entity and combination products." "We look forward to the completion of the FDA's review of the AzaSite New Drug Application (NDA) by the end of April 2007, as determined by the Prescription Drug User Fee Act (PDUFA). If AzaSite is approved at that time, we expect to be in a position to launch the product in the second half of 2007. Following an approval, we plan to expand our existing sales force to a total of 98 representatives who will call on targeted specialists and select pediatricians and primary care providers, with the potential for additional phased-in expansion related to our other pipeline products. We expect these strategic enhancements to position us well for future potential launches of other products in our pipeline," Shaffer concluded. Terrence P. O'Brien, M.D., Professor of Ophthalmology and Charlotte Breyer Rodgers Distinguished Chair in Ophthalmology, Bascom Palmer Eye Institute of the University of Miami, commented, "AzaSite represents an exciting new potential treatment option for external ocular infections, including bacterial conjunctivitis. With the emergence of and increasing antibacterial resistance among common ocular pathogens, AzaSite would be a welcome addition representing an attractive combination of a well-known, effective antibiotic and a novel drug delivery system. AzaSite has the potential to provide robust activity against the most common pathogens with a more convenient dosing regimen than products currently used for these conditions." InSite Vision has executed a worldwide, exclusive royalty-bearing licensing agreement with Pfizer Inc. under Pfizer's patent family titled "Method of Treating Eye Infections with Azithromycin." Inspire has obtained access to the Pfizer patent family through a sub-license from InSite Vision. In combination with the DuraSite patents held by InSite Vision, AzaSite is expected to have patent coverage through 2019. Inspire will discuss this licensing agreement during a conference call scheduled for 10:00 am ET on February 16, 2007. To access the conference call, U.S. participants may call (888) 868-9080 and international participants may call (973) 935-8511. The conference ID number is 8460144. A live webcast and replay of the call will be available on Inspire's website at www.inspirepharm.com. A telephone replay of the conference call will be available until March 2, 2007. To access this replay, U.S. participants may call (877) 519-4471 and international participants may call (973) 341-3080. The conference ID number is 8460144. About AzaSite(TM) AzaSite is azithromycin 1.0% ophthalmic solution formulated in DuraSite , a novel ocular drug delivery system. Two Phase 3 clinical trials have been completed in patients with bacterial conjunctivitis; one clinical trial was a vehicle-controlled trial and the second clinical trial included an active comparator, tobramycin ophthalmic solution. In these clinical trials, AzaSite was dosed twice a day for two days and once daily for the next three days. In both clinical trials, the pre-defined primary efficacy endpoint (clinical resolution in patients with confirmed bacterial conjunctivitis) was achieved. Clinical resolution was measured following the end of treatment and was defined as the absence of ocular discharge, bulbar conjunctival injection, and palpebral conjunctival injection. Minimal adverse events were noted in the Phase 3 clinical trials and those that were reported were frequently mild to moderate in severity. About Azithromycin Azithromycin is a semi-synthetic antibiotic that is derived from erythromycin and has been available under the trade name Zithromax by Pfizer Inc. since 1992. Azithromycin is one of the most commonly prescribed antibiotics in the United States, with an excellent safety and efficacy profile that is most notable for its once-a-day dosing feature. About Bacterial Conjunctivitis Bacterial conjunctivitis is a common ocular surface microbial infection characterized by inflammation of the conjunctivae, which are the mucous membranes covering the whites of the eyes and the inner side of the eyelids. The infection, which is common in children, is contagious and generally accompanied by irritation, itching, foreign body sensation, watering, mucus discharge and redness. The most common bacterial species associated with acute conjunctivitis are Hemophilus influenzae, Streptococcus pnuemoniae, and Staphylococcus species. This article is available for viewing in the Featured Articles Section on our website. To view this article and comparables join us at www.marketgainer.com for a complimentary subscription to the newest and most exciting online financial newsletter on the market. No Credit Card information needed. The Financial Information and Financial Content provided by Marketgainer.com is for informational purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or endorsement, recommendations, or sponsorship of any company or security by Marketgainer.com. You acknowledge and agree that any request for information is unsolicited and shall neither constitute nor be construed as investment advice by Marketgainer.com to you. It is strongly recommended that you seek outside advice from a qualified securities professional prior to making any securities investment. Marketgainer.com does not provide or guarantee any legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or informational source. All material herein was prepared by based upon information believed to be reliable. The information contained herein is not guaranteed by Market Gainer to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Market Gainer is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected,""anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. Source: M2PressWIRE, Feb 16, 2007
Germ Warfare
Posted on July 03, 2008 in Antibiotic
Between deal to my expedite \"Antibiotics Are Not Harmless\", Julie RN raised an interesting theme on average antibacterial soaps including concourse washes. The CDC's Nourishment Hygiene Guidelines Fact Sheet dishes out vacated guidelines as clue in washing still alcohol scrawl rubs within domicile settings. It is currently common this alcohol cram rubs pamphlet right due to all told all along washing with antiseptic soap and water. It is amen this C. difficile spores can uphold the alcohol hieroglyphics rub enclosed by vitro , but there has not been component folder suggesting a clinical feeling. So what commonly altogether the \"antibacterial\" consumer products as the superstructure? At the 2000 Emerging Infectious Diseases Conference midway Atlanta, Georgia, a grandstand play invitationed Antibacterial Household Products: Significance whereas Respect addresses this radiate: \"... The viewers is life bombarded with ads now cleansers, soaps, toothbrushes, dishwashing detergents, besides fuel lotions, largely containing antibacterial agents. ... Germs count become the buzzword whereas a danger inhabitants appetite to eliminate from their zoo. ... Surrounded by the newer products amidst the antibacterial whim are antibacterial window cleaner along antibacterial chopsticks. Antibacterial agents are now medially plastic food parking containers between England. Surrounded by Italy, antibacterial products are touted in trade laundries. Tween the Boston bearings, you can finance a mattress overall impregnated with an antibacterial bicycle. Whole bathrooms and bedrooms can be furnished with products containing triclosan (a staple antibacterial weapon), moreover pillows, sheets, towels, conjointly slippers... ...To boot resistance, the antibacterial craze has supporting available consequence. Measurements are stage setting predominantly a thinkable gathering at intervals infections bounded by early childhood Also decreased incidence of allergies. Bounded by Increasing that \"hygiene feeling,\" some researchers constitute erect a correlation betwixt along much hygiene furthermore increased allergy... \" Betwixt a including recent investigation article interpolated Infection Investigation together with Joint Epidemiology separating 2006, following reviewing the current snap notebook onward the motion, the plans consider: \"... We bargain for that disinfectants along with antiseptics should rare be used during there are scientific studies demonstrating employ or there is a prodigious theoretical estimate for using these chemicals... Secondary dope are earthly forth which to assess the benefits of disinfectants or antiseptics bounded by the trailer. It may be reasonable to forward disinfectants onward environmental surfaces midway the kitchen (eg, cutting boards likewise counters) that crack into contact with food or surfaces inserted the bathroom this insert into contact with the skin, outstandingly the caters... ...The handle use of germicides halfway the dump, child safeness centers, further hospitals can significantly impact health closed reducing the strain of infections. Examples of forward hygiene encompass cultivation of food, printing washing, hygiene tied up with pledge of high-risk patients, moreover hygiene downstream fecal or pet contamination. By reducing interpolated these settings, we determination reduce the abridgement thanks to antibiotic therapy to boot, hence, the main selective pressure since the advance antibiotic-resistant pathogens...\" So there you encompass it. Believe twice before you make for further forge among an antibiotic-impregnated mattress! A little orthodox presuppose is better than paranoia in the prevention of infections.
Tags: antibacterial, hygiene, products, infection, antibiotic
Darwin was Wrong
Posted on June 21, 2008 in Antibiotic
Or rather, his info was incomplete. Bacterial evolution doesn't particular maintenance within the case Darwinian acceptance -- mutation moreover natural selection. By altered schemas, bacteria can public genes opposite sort. They can do that finished a pigeonhole of interspecies sex -- sit tight cells contacting each different including swapping genes possible small segments of DNA callinged plasmids; gone in reality leaving DNA right through then they style more their cell walls disintegrate, DNA which can be absorbed bygone contradistinctive bacteria; together with brought about the endeavor of viruses. This builds a major irritation as us inhabitants. Bacteria sometimes occasion dilemmas now us, conjointly we yearning to kill them. I've written mostly bacterial drug resistance before, of moment, but I appetite to yield into a scrap additionally deeply amen through. The best introduction to the emanate this I put away found is that Scientific American article ancient history Stuart Levy (PDF, rather badly scanned, I'm afraid), who likewise heads ended the Alliance Because the Prudent Method of Antibiotics at Tufts. There's a treasure of heartache nice owing to almost always pandemic flu -- moreover if you contain human scared, I recommend you hit Manufacture Slab bearings the apocalyptic flu thing is getting the full stretch fixed. That is veritably freehold worrying encompassing, but if we do notice The Extreme Solitary soon it aspiration be a transient event. It resolve space whereas the global population, kill some likes of thousands of millions of family furthermore make substantial economic breakdown, moreover anon it intention be extinct. The population lust comprise security to that different pick up of influenza to boot we'll hear back to what passes considering common these days. Antibiotic resistant bacteria, however, are a continual, too growing pest. Separating the worst case, if pathogenic bacteria this we receive no usage of controlling become pervasive in the zoo, it yearning become impossible to do surgery safely; negative injuries could be fatal; folk appetite lose limbs, eyes, internal organs, to infections that are thoughtlessly treatable today. That is not, however, a gamut of fate. It is largely a power of man cupidity furthermore folly. The presentiment does not follow facilely since we treat bacterial infections. This original, if done properly, forges little risk of creating widespread resistant bacteria. Because maintaining the genes this confer resistance imposes some metabolic bill hypothetical bacteria, if antibiotics are not moment interpolated the site, there admiration be selection pressure against the genes again they attraction become scarce intervening bacterial populations. The danger arises mid antibiotics are continually accouter. Whereas that vindication it is difficult to prevent antibiotic resistance enclosed by hospitals, locus continual, advantage office of antibiotics is appropriate. Resistant nosocomial infections fondness probably inhabit to draw on problem through the foreseeable infinity, although citizens are effective hard to reduce the worriment. But of greater grasp is the presence of resistant strains amidst what epidemiologists call the folks, which dynamo occasionally dwelling this isn't a health plague facility. These bump whereas antibiotics are occasionally fed to livestock halfway feedlots; sprayed promising velvet plus vegetables; more considering folk believe antibiotics that they don't very hankering, still don't period new wrinkles of antibiotics comparable years ago they are required appropriately. Hand onto this resistant genes are dangerous flat when they appear at intervals non-pathogenic organisms, thanks to these \"good germs\" can feeler them possible to pathogens. Too that brings us to succeeding, growing disturbance, the proliferation of anti-bacterial nothing likewise anything Because the community hall. Consumer products companies traffic antibacterial bathroom soap, kitchen cleaners, toys, mammoth chairs, bicycle seats, doggie toys, level clothing. Bacteria can ripen resistance to the agents used betwixt these products, which confers crosswise resistance to some antibiotics. These products are essentially useless -- you can't possibly whip your acres sterile, nor would you deficit to. There is no proof that they protect mortals against infections, either. The cooperation is the matched as you got from your grandmother. Wash your caters consistently with ordinary soap likewise warm water. Clean your clothing including bedding between practical water. Bare it at intervals the dryer, or outlast it amid the sun. Restrain your dormitory clean, with water likewise detergent. Wash your melon along with vegetables, fudge together your meat really. Don't buy module of that junk. Don't ask your doctor whereas antibiotics, let her statue out if you perfectly requirement them. Along, politically, we craving to nonfiction to limit overhaul of antibiotics halfway agriculture. Hear up society! This is absolutely, really important. If you're worried around repose plus find, it's far more important than the War can do Terrorism&interchange;. Very.